BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36300562)

  • 1. Time to resolution of iodine-123 metaiodobenzylguanidine (
    Oh J; Gutkin P; Wang YP; Sandhu N; Majzner RG; Nadel H; Shimada H; Lansinger O; von Eyben R; Donaldson S; Bruzoni M; Sodji QH; Hiniker SM
    J Med Imaging Radiat Oncol; 2023 Feb; 67(1):81-88. PubMed ID: 36300562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
    Mazloom A; Louis CU; Nuchtern J; Kim E; Russell H; Allen-Rhoades W; Krance R; Paulino AC
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):858-62. PubMed ID: 25245583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of iodine-131 MIBG scanning in the management of paediatric patients with neuroblastoma.
    Shah Syed GM; Naseer H; Usmani GN; Cheema MA
    Med Princ Pract; 2004; 13(4):196-200. PubMed ID: 15181323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma.
    Andrich MP; Shalaby-Rana E; Movassaghi N; Majd M
    Pediatrics; 1996 Feb; 97(2):246-50. PubMed ID: 8584386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
    Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
    Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Aboian MS; Huang SY; Hernandez-Pampaloni M; Hawkins RA; VanBrocklin HF; Huh Y; Vo KT; Gustafson WC; Matthay KK; Seo Y
    J Nucl Med; 2021 Jan; 62(1):43-47. PubMed ID: 32414950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
    Yanik GA; Parisi MT; Shulkin BL; Naranjo A; Kreissman SG; London WB; Villablanca JG; Maris JM; Park JR; Cohn SL; McGrady P; Matthay KK
    J Nucl Med; 2013 Apr; 54(4):541-8. PubMed ID: 23440556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
    Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
    Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic patterns of relapse and progression following treatment with
    Fishel Ben Kenan R; Polishchuk AL; Hawkins RA; Braunstein SE; Matthay KK; DuBois SG; Haas-Kogan DA
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29396. PubMed ID: 34662499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography.
    Lastoria S; Maurea S; Caracò C; Vergara E; Maurelli L; Indolfi P; Casale F; di Tullio MT; Salvatore M
    Eur J Nucl Med; 1993 Dec; 20(12):1161-7. PubMed ID: 8299651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
    Suc A; Lumbroso J; Rubie H; Hattchouel JM; Boneu A; Rodary C; Robert A; Hartmann O
    Cancer; 1996 Feb; 77(4):805-11. PubMed ID: 8616776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.
    Giammarile F; Lumbroso J; Ricard M; Aubert B; Hartmann O; Schlumberger M; Parmentier C
    Eur J Nucl Med; 1995 Oct; 22(10):1180-3. PubMed ID: 8542903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma.
    Hickeson MP; Charron M; Maris JM; Brophy P; Kang TI; Zhuang H; Khan J; Nevrotski T
    Pediatr Blood Cancer; 2004 Mar; 42(3):268-74. PubMed ID: 14752865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma.
    Polishchuk AL; Li R; Hill-Kayser C; Little A; Hawkins RA; Hamilton J; Lau M; Tran HC; Strahlendorf C; Lemons RS; Weinberg V; Matthay KK; DuBois SG; Marcus KJ; Bagatell R; Haas-Kogan DA
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):839-45. PubMed ID: 24867534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
    Murashima S; Takeda K; Okuda Y; Nakagawa T; Sakurai M
    Kaku Igaku; 1990 Dec; 27(12):1393-400. PubMed ID: 2290210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
    Kushner BH; Yeh SD; Kramer K; Larson SM; Cheung NK
    J Clin Oncol; 2003 Mar; 21(6):1082-6. PubMed ID: 12637474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
    Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
    Klingebiel T; Reuland P; Feine U; Niethammer D
    Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.